Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,931 | 383 | 97.9% |
| Education | $127.21 | 5 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $921.72 | 58 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $897.76 | 63 | $0 (2022) |
| Lilly USA, LLC | $755.99 | 58 | $0 (2023) |
| PFIZER INC. | $509.33 | 28 | $0 (2023) |
| Novo Nordisk Inc | $426.06 | 30 | $0 (2023) |
| Astellas Pharma US Inc | $400.18 | 20 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $291.28 | 18 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $240.09 | 15 | $0 (2022) |
| GlaxoSmithKline, LLC. | $229.09 | 14 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $166.28 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.43 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($22.43) |
| 2023 | $563.85 | 32 | Lilly USA, LLC ($170.01) |
| 2022 | $807.69 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($162.86) |
| 2021 | $1,223 | 75 | Boehringer Ingelheim Pharmaceuticals, Inc. ($154.24) |
| 2020 | $760.13 | 49 | AstraZeneca Pharmaceuticals LP ($194.71) |
| 2019 | $796.02 | 50 | AstraZeneca Pharmaceuticals LP ($192.13) |
| 2018 | $906.30 | 68 | AstraZeneca Pharmaceuticals LP ($233.03) |
| 2017 | $978.86 | 68 | AstraZeneca Pharmaceuticals LP ($187.08) |
All Payment Transactions
388 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Gastroenterology | ||||||
| 12/13/2023 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
| 11/27/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: PAIN | ||||||
| 11/16/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Gastroenterology | ||||||
| 11/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: DIABETES | ||||||
| 11/02/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Diabetes | ||||||
| 10/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Diabetes | ||||||
| 09/20/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes | ||||||
| 08/07/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: DIABETES | ||||||
| 07/26/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Oncology | ||||||
| 07/19/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/03/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Diabetes | ||||||
| 06/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: DIABETES | ||||||
| 06/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 06/07/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Biological | ||||||
| 05/22/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Embecta Corp. | BD Nano 2nd Gen Pen Needle (Device) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Diabetes Care | ||||||
| 04/18/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Obesity | ||||||
| 03/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: DIABETES | ||||||
| 03/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Diabetes | ||||||
| 03/20/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.09 | General |
| Category: Cardiovascular | ||||||
| 03/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 02/22/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 355 | 468 | $49,813 | $27,357 |
| 2022 | 11 | 484 | 647 | $68,055 | $39,058 |
| 2021 | 17 | 980 | 1,473 | $151,175 | $86,072 |
| 2020 | 18 | 1,413 | 1,910 | $176,111 | $85,964 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 200 | $31,000 | $16,344 | 52.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $9,030 | $5,578 | 61.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 22 | 22 | $2,090 | $1,668 | 79.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 24 | $2,670 | $1,420 | 53.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $1,215 | $843.75 | 69.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 33 | 33 | $825.00 | $606.87 | 73.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 49 | 50 | $2,100 | $379.29 | 18.1% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 20 | 20 | $540.00 | $353.80 | 65.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 46 | 49 | $343.00 | $163.68 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 255 | $38,250 | $21,024 | 55.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 75 | 75 | $15,750 | $9,987 | 63.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 30 | 30 | $2,550 | $2,108 | 82.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $2,090 | $1,623 | 77.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 44 | $1,730 | $1,314 | 76.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 21 | $2,310 | $1,095 | 47.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 72 | 75 | $3,150 | $568.47 | 18.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 24 | 24 | $648.00 | $427.80 | 66.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 13 | 13 | $650.00 | $379.56 | 58.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 77 | 86 | $602.00 | $292.29 | 48.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 13 | 13 | $325.00 | $240.37 | 74.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 201 | 580 | $85,096 | $48,702 | 57.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 115 | 115 | $24,150 | $15,578 | 64.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 113 | $12,430 | $6,757 | 54.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 63 | 63 | $5,355 | $4,185 | 78.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 24 | $4,560 | $3,040 | 66.7% |
About Dr. David Wolf, MD
Dr. David Wolf, MD is a Internal Medicine healthcare provider based in Bingham Farms, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447339460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Wolf, MD has received a total of $6,058 in payments from pharmaceutical and medical device companies, with $22.43 received in 2024. These payments were reported across 388 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,931).
As a Medicare-enrolled provider, Wolf has provided services to 3,232 Medicare beneficiaries, totaling 4,498 services with total Medicare billing of $238,451. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Bingham Farms, MI
- Active Since 11/02/2006
- Last Updated 02/03/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447339460
Products in Payments
- FARXIGA (Drug) $717.83
- ELIQUIS (Drug) $453.94
- TRULICITY (Drug) $330.44
- STIOLTO RESPIMAT (Drug) $306.44
- TRADJENTA (Drug) $303.51
- Livalo (Drug) $240.09
- JARDIANCE (Drug) $234.04
- CHANTIX (Drug) $219.26
- MYRBETRIQ (Drug) $210.12
- PRADAXA (Drug) $177.43
- JANUVIA (Drug) $166.28
- VYVANSE (Drug) $126.40
- NURTEC ODT (Drug) $126.07
- Ozempic (Drug) $125.46
- TRELEGY ELLIPTA (Drug) $124.66
- VRAYLAR (Drug) $108.40
- XARELTO (Drug) $98.46
- UBRELVY (Drug) $93.62
- Saxenda (Drug) $85.95
- Repatha (Biological) $85.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bingham Farms
Justin Trivax, M.d, M.D
Internal Medicine — Payments: $190,785
Dr. Leo Reap, D.o, D.O
Internal Medicine — Payments: $4,333
Karen Russell-Little, M.d, M.D
Internal Medicine — Payments: $1,274
Joseph Hagen, Do, DO
Internal Medicine — Payments: $428.78
Dr. Yale Halpern, Md, MD
Internal Medicine — Payments: $78.48
Andrey Lutskovsky, Do, DO
Internal Medicine — Payments: $59.31